Temporal and spatial distribution of interleukin-1β in balloon injured porcine coronary arteries

被引:50
作者
Chamberlain, J [1 ]
Gunn, J [1 ]
Francis, S [1 ]
Holt, C [1 ]
Crossman, D [1 ]
机构
[1] Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Div Clin Sci,Sect Med,NGH, Sheffield S5 7AU, S Yorkshire, England
关键词
angioplasty; arteries; cytokines; endothelial factors; restenosis;
D O I
10.1016/S0008-6363(99)00175-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine with a wide range of biological activities. We determined the distribution of IL-1 beta following percutaneous transluminal coronary angioplasty (PTCA) of porcine arteries, and the presence of caspase-1 (required for the activation of IL-1 beta). Methods: Oversized balloon angioplasty was performed in Yorkshire White pigs and the vessels excised at selected intervals (1, 6, 18 h, 3, 7, and 14 days) post-PTCA. IL-1 beta and caspase-1 were then identified using reverse transcription polymerase chain reaction (RT-PCR), in situ RT-PCR, and immunohistochemistry. Results: IL-1 beta protein was detected in the inflammatory infiltrate up to 3 days after PTCA. Luminal endothelial cells contained IL-1 beta at 1 h, with peak expression at 3-7 days. Adventitial capillaries were IL-1 beta-positive at all timepoints. IL-1 beta was detected in adventitial cells at 3 days, with reduced levels at 7 and 14 days. At 7 days, neointimal cells were also IL-1 beta positive. No IL-1 beta was detected in non-PTCA control arteries. RT-PCR demonstrated IL-1 beta mRNA expression to be induced at 1 h, and absent at 3 days. In situ RT-PCR revealed this expression to be distributed throughout the arterial layers at 6 h, but localized to the adventitia at 18 h, with a baseline expression in the adventitial layer of non-PTCA controls. Caspase-beta was detected in luminal endothelial cells from 6 h, in adventitial cells from 3 days, and in neointimal cells from 7 days post-PTCA. This expression colocalized with IL-1 beta, indicating the potential for the IL-1 beta present to become activated. Conclusions: We conclude that IL-1 beta is synthesised, in conjunction with caspase-1, by endothelial, inflammatory, and adventitial cells early (within 3 days) after PTCA, with decreased levels at later timepoints, suggesting that it has a key role to play in the early stages of healing following PTCA. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:156 / 165
页数:10
相关论文
共 54 条
[1]   CLONING AND EXPRESSION OF 4 NOVEL ISOFORMS OF HUMAN INTERLEUKIN-1-BETA CONVERTING-ENZYME WITH DIFFERENT APOPTOTIC ACTIVITIES [J].
ALNEMRI, ES ;
FERNANDESALNEMRI, T ;
LITWACK, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4312-4317
[2]   INTERLEUKIN-1 INHIBITS CONTRACTION OF VASCULAR SMOOTH-MUSCLE [J].
BEASLEY, D ;
COHEN, RA ;
LEVINSKY, NG .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (01) :331-335
[3]   RECOMBINANT TUMOR-NECROSIS-FACTOR INDUCES PROCOAGULANT ACTIVITY IN CULTURED HUMAN VASCULAR ENDOTHELIUM - CHARACTERIZATION AND COMPARISON WITH THE ACTIONS OF INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
FIERS, W ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4533-4537
[4]   INTERLEUKIN-1 ACTS ON CULTURED HUMAN VASCULAR ENDOTHELIUM TO INCREASE THE ADHESION OF POLYMORPHONUCLEAR LEUKOCYTES, MONOCYTES, AND RELATED LEUKOCYTE CELL-LINES [J].
BEVILACQUA, MP ;
POBER, JS ;
WHEELER, ME ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :2003-2011
[5]  
BLACK RA, 1988, J BIOL CHEM, V263, P9437
[6]   INTERLEUKIN-1 PROMOTES PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS IN COORDINATION WITH PDGF OR A MONOCYTE DERIVED GROWTH-FACTOR [J].
BONIN, PD ;
FICI, GJ ;
SINGH, JP .
EXPERIMENTAL CELL RESEARCH, 1989, 181 (02) :475-482
[7]  
CAVENDER DE, 1986, J IMMUNOL, V136, P203
[8]  
Chamberlain J., 1996, European Heart Journal, V17, P195
[9]  
Chinnaiyan AM, 1996, CURR BIOL, V6, P555
[10]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2